Intrinsic Value of S&P & Nasdaq Contact Us

Exelixis, Inc. EXEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
83/100
6/7 Pass
SharesGrow Intrinsic Value
$125.10
+172.8%
Analyst Price Target
$44.11
-3.8%

Exelixis, Inc. (EXEL) has a consensus analyst rating of Buy, based on 32 analysts covering the stock. Of those, 16 recommend buying, 16 recommend holding, and 0 recommend selling.

The analyst consensus price target for EXEL is $44.11, representing a -3.8% downside from the current price of $45.86. Price targets range from a low of $30.00 to a high of $54.00.

Analyst Consensus — EXEL

Buy
Strong Buy
0
Buy
16
Hold
16
Sell
0
Strong Sell
0
32 analysts
Price Targets
Consensus$44.11
High$54.00
Low$30.00
Median$44.00
Last Month Avg-
Last Quarter Avg$48.86
Last Year Avg$45.44
All-Time Count53
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message